Taking desogestrel and Wegovy together: what changes, and what doesn't

Step 1: understand what Wegovy actually does to your digestive system

Wegovy works by activating GLP-1 receptors in the brain and gut. One well-documented effect is delayed gastric emptying: food, liquid and anything else you swallow moves through your stomach more slowly than usual. For most people this contributes to feeling fuller for longer, which is part of how the medicine supports weight loss. For anyone on an oral medicine taken daily (including a progestogen-only pill like desogestrel) it raises a reasonable question about whether absorption is affected.

The honest answer is that the evidence is more nuanced than a simple yes or no. Semaglutide does delay gastric emptying, particularly in the early weeks of treatment and after dose increases. However, peak absorption of desogestrel and its active metabolite etonogestrel happens relatively quickly after swallowing, and the clinical data gathered during Wegovy's trials did not demonstrate a meaningful reduction in contraceptive hormone levels. NHS England's guidance on weight-management injections notes no equivalent evidence of reduced pill effectiveness for semaglutide, a distinction it draws explicitly against tirzepatide, where the concern is more established.

That said, if you experience significant vomiting or severe nausea during the adjustment period, usual missed-pill rules may apply as they would after any illness. Your prescriber and the Patient Information Leaflet are the right reference points for that scenario.

Step 2: know where desogestrel sits differently from other pills

Not all oral contraceptives carry the same theoretical risk. The combined oral contraceptive pill relies on sustained oestrogen and progestogen levels; even modest reductions in absorption could, in principle, affect its reliability. Desogestrel, as a progestogen-only pill, works largely by thickening cervical mucus rather than by suppressing ovulation in every cycle. This mechanism is less dependent on a precise peak blood level than combined pills, which is part of why the concern about semaglutide and desogestrel specifically is lower.

That distinction matters when you are reading general advice about GLP-1 medicines and contraception. Much of what circulates online conflates the Mounjaro rule (where the MHRA and NHS Inform Scotland are explicit that oral contraceptive users should add a barrier method for the first four weeks and after each dose increase) with Wegovy's profile. They are different medicines with different pharmacology, and the clinical guidance reflects that.

If you are considering moving from semaglutide to tirzepatide at any point, the contraception conversation would need revisiting. A clinician can walk through what that transition means for you personally. You can read more about how progesterone-based contraceptives interact with Wegovy in more detail if that context is useful.

Step 3: tell every clinician involved what you are taking

This is not a dramatic instruction, it is just good clinical practice. Your Wegovy prescriber needs to know you take desogestrel, and your GP or sexual health clinician who manages your contraception should know you are on a weight-loss injection. Neither is likely to change the other's recommendation, but gaps in that picture are how small risks become larger ones.

Weight loss itself can affect hormone metabolism. As body composition changes over months of treatment, some people notice shifts in cycle regularity or the way their body responds to hormonal contraception. This is not well-characterised in the current literature, and it is not a reason to stop either treatment, but it is a reason to keep both sets of clinicians informed. Our clinical team at nume reviews your full medication list before any prescription is issued and at every repeat. If you are ever unsure what to flag, the answer is: flag everything.

One practical note: if you are planning to start Wegovy around a break in routine (a summer holiday, a bank holiday weekend) think about timing your first pen so your prescriber is reachable in the days that follow. Early side effects tend to be mild, but having someone to contact if you are uncertain costs nothing. Our FAQ page covers what to do if you have questions between reviews.

When to speak to a prescriber rather than read on

If you are experiencing persistent vomiting in the first weeks of Wegovy treatment, that is worth raising with a clinician promptly, partly because dehydration matters, and partly because standard contraceptive guidance around vomiting would apply as it would with any oral medicine. You can also find out how B12 fits into your Wegovy treatment plan, which is a useful additional consideration when managing your overall health during weight loss. The NHS semaglutide medicines page is a reliable first reference for what symptoms are expected and which warrant contact.

There is also a broader group of people for whom the desogestrel and Wegovy conversation touches on related topics: those managing other conditions alongside weight loss, or those whose GP has raised questions about bone health or mood on the progestogen-only pill. Some of those questions intersect with Wegovy and MS, or general questions about how semaglutide affects other body systems. None of these are reasons to delay a conversation with a prescriber, they are reasons to have a more complete one.

If you are ready to explore whether Wegovy is clinically suitable for you, the right place to start is a consultation where your full medication history, including desogestrel, is part of the assessment. Check your eligibility with our prescribers at no cost, with same-day clinical review once you submit.